XML 66 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Share-Based Payments (Tables)
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Share-based compensation expense included in condensed consolidated statements of income
The following table summarizes share-based compensation expense included in our condensed consolidated statements of income:
For the Three Months Ended March 31,
(In millions)20212020
Research and development $33.6 $33.3 
Selling, general and administrative44.9 43.1 
Subtotal78.5 76.4 
Capitalized share-based compensation costs (2.6)(1.5)
Share-based compensation expense included in total cost and expense75.9 74.9 
Income tax effect(14.0)(13.3)
Share-based compensation expense included in net income attributable to Biogen Inc.$61.9 $61.6 
Summary of share-based compensation expense associated with each of our share-based compensating programs
The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:
For the Three Months Ended March 31,
(In millions)20212020
Market stock units$16.5 $19.1 
Time-vested restricted stock units42.8 37.5 
Cash settled performance units— (1.6)
Performance units— (0.1)
Performance stock units settled in stock6.3 10.3 
Performance stock units settled in cash6.0 8.9 
Employee stock purchase plan6.9 2.3 
Subtotal78.5 76.4 
Capitalized share-based compensation costs(2.6)(1.5)
Share-based compensation expense included in total cost and expense$75.9 $74.9